These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18766151)

  • 21. [From symptomatic to disease modifying therapy? Recent developments in the pharmacotherapy of Alzheimer's disease].
    Franke AG; Lieb K; Fellgiebel A
    Fortschr Neurol Psychiatr; 2009 Jun; 77(6):326-33. PubMed ID: 19504422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of neuroimmunomodulation in Alzheimer's disease.
    Maccioni RB; Rojo LE; Fernández JA; Kuljis RO
    Ann N Y Acad Sci; 2009 Feb; 1153():240-6. PubMed ID: 19236346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications.
    El Khoury J; Luster AD
    Trends Pharmacol Sci; 2008 Dec; 29(12):626-32. PubMed ID: 18835047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease-modifying therapies in Alzheimer's disease.
    Salloway S; Mintzer J; Weiner MF; Cummings JL
    Alzheimers Dement; 2008 Mar; 4(2):65-79. PubMed ID: 18631951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-inflammatory therapy in Alzheimer's disease: is hope still alive?
    van Gool WA; Aisen PS; Eikelenboom P
    J Neurol; 2003 Jul; 250(7):788-92. PubMed ID: 12883918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of tau aggregation inhibitors for Alzheimer's disease.
    Bulic B; Pickhardt M; Schmidt B; Mandelkow EM; Waldmann H; Mandelkow E
    Angew Chem Int Ed Engl; 2009; 48(10):1740-52. PubMed ID: 19189357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization in Alzheimer's disease: naïve hope or realistic clinical potential?
    Foster JK; Verdile G; Bates KA; Martins RN
    Mol Psychiatry; 2009 Mar; 14(3):239-51. PubMed ID: 18957942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory processes in Alzheimer's disease.
    Heneka MT; O'Banion MK
    J Neuroimmunol; 2007 Mar; 184(1-2):69-91. PubMed ID: 17222916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of inflammation in Alzheimer's disease pathogenesis and therapeutic potential of anti-inflammatory agents.
    Shadfar S; Hwang CJ; Lim MS; Choi DY; Hong JT
    Arch Pharm Res; 2015 Dec; 38(12):2106-19. PubMed ID: 26289122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammation and therapeutic vaccination in CNS diseases.
    Weiner HL; Selkoe DJ
    Nature; 2002 Dec 19-26; 420(6917):879-84. PubMed ID: 12490962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The treatment of Alzheimer's disease].
    Ankri J
    Rev Neurol (Paris); 2003 Sep; 159(8-9):819-24. PubMed ID: 13679729
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin.
    Ray B; Lahiri DK
    Curr Opin Pharmacol; 2009 Aug; 9(4):434-44. PubMed ID: 19656726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model.
    Lee JK; Jin HK; Bae JS
    Neurosci Lett; 2009 Jan; 450(2):136-41. PubMed ID: 19084047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tauists, Baptists, Syners, Apostates, and new data.
    Trojanowski JQ
    Ann Neurol; 2002 Sep; 52(3):263-5. PubMed ID: 12205637
    [No Abstract]   [Full Text] [Related]  

  • 36. Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.
    Hampel H; Ewers M; Bürger K; Annas P; Mörtberg A; Bogstedt A; Frölich L; Schröder J; Schönknecht P; Riepe MW; Kraft I; Gasser T; Leyhe T; Möller HJ; Kurz A; Basun H
    J Clin Psychiatry; 2009 Jun; 70(6):922-31. PubMed ID: 19573486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The inflammation in Alzheimer's disease].
    Liao WH; Wang WJ
    Sheng Li Ke Xue Jin Zhan; 2004 Apr; 35(2):181-4. PubMed ID: 15285432
    [No Abstract]   [Full Text] [Related]  

  • 38. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.
    Song MS; Rauw G; Baker GB; Kar S
    Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aneuploidy, chromosomal missegregation, and cell cycle reentry in Alzheimer's disease.
    Zekanowski C; Wojda U
    Acta Neurobiol Exp (Wars); 2009; 69(2):232-53. PubMed ID: 19593337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammation takes on Alzheimer disease.
    Golde TE
    Nat Med; 2002 Sep; 8(9):936-8. PubMed ID: 12205453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.